Expression of Nectin-4 in Bladder Urothelial Carcinoma, in Morphologic Variants, and Nonurothelial Histotypes

Jean Hoffman‐Censits(Sidney Kimmel Comprehensive Cancer Center), Andrés Matoso(Johns Hopkins University), Woonyoung Choi(Johns Hopkins University), Vamsi Parimi(Johns Hopkins University), David J. McConkey(Johns Hopkins University), Trinity J. Bivalacqua(University of Pennsylvania), Kara A. Lombardo(Johns Hopkins University), Bridget McGuire(Sidney Kimmel Comprehensive Cancer Center), Noah M. Hahn(Johns Hopkins University), Max Kates(Duke Medical Center), Sonia Kamanda(Johns Hopkins University)
Applied immunohistochemistry & molecular morphology
April 23, 2021
10.1097/pai.0000000000000938
Cited by 161

Related Papers

Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
|The Lancet|2016|3.7k
Neurohumoral Features of Myocardial Stunning Due to Sudden Emotional Stress
|New England Journal of Medicine|2005|3.1k
Comprehensive molecular characterization of urothelial bladder carcinoma
|Nature|2014|3.1k
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
|New England Journal of Medicine|2015|2.8k
Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer
|Cell|2017|2.5k